Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Completed · Phase 3

Conditions studied: Schizophrenia, Schizoaffective Disorder

In brief

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is safe and tolerable long term among clinically stable patients. The study will also assess the long term effectiveness of lurasidone as compared to an active comparator.

Key facts

Study ID
NCT00641745
Run by
Sumitomo Pharma America, Inc.
People needed
629
Starts
2008-03-01
Expected to finish
2010-07-01
Last updated by the study team
2015-06-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.